0001584476-14-000003.txt : 20140905 0001584476-14-000003.hdr.sgml : 20140905 20140905164923 ACCESSION NUMBER: 0001584476-14-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140905 DATE AS OF CHANGE: 20140905 EFFECTIVENESS DATE: 20140905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RxInnovation Inc. CENTRAL INDEX KEY: 0001557336 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-183753 FILM NUMBER: 141086439 BUSINESS ADDRESS: STREET 1: 2601 SCOTT AVENUE STREET 2: SUITE 600 CITY: FORT WORTH STATE: TX ZIP: 76103 BUSINESS PHONE: (443) 573-3717 MAIL ADDRESS: STREET 1: 2601 SCOTT AVENUE STREET 2: SUITE 600 CITY: FORT WORTH STATE: TX ZIP: 76103 FORMER COMPANY: FORMER CONFORMED NAME: Lagniappe Health, Inc. DATE OF NAME CHANGE: 20120831 D/A 1 primary_doc.xml X0707 D/A LIVE 0001557336 RxInnovation Inc. 2601 SCOTT AVENUE SUITE 600 FORT WORTH TX TEXAS 76103 (443) 573-3717 DELAWARE Lagniappe Health, Inc. Corporation true 2011 Josh Hall c/o Calvert Street Capital Partners 111 South Calvert Street, Suite 1800 Baltimore MD MARYLAND 21202 Director Josh Hall is a Director of the Issuer. Jacob Canova 2601 SCOTT AVENUE SUITE 600 FORT WORTH TX TEXAS 76103 Executive Officer Director Jacob Canova is the CEO and Director of the Issuer. Peter Fianu 2601 SCOTT AVENUE SUITE 600 FORT WORTH TX TEXAS 76103 Executive Officer Director Peter Fianu is the CIO and Executive Vice-President and Director of the Issuer. John Wissel c/o Calvert Street Capital Partners 111 South Calvert Street, Suite 1800 Baltimore MD MARYLAND 21202 Executive Officer John Wissel is the Secretary of the Issuer. Michael Booth c/o Calvert Street Capital Partners 111 South Calvert Street, Suite 1800 Baltimore MD MARYLAND 21202 Executive Officer Director Michael Booth is the Chairman, President and Treasurer. Harlan Seymour 2601 SCOTT AVENUE SUITE 600 FORT WORTH TX TEXAS 76103 Director Harlan Seymour is a Director of the Issuer. Richard Bukovinsky 2601 SCOTT AVENUE SUITE 600 FORT WORTH TX TEXAS 76103 Executive Officer Director Richard Bukovinsky is an Executive Vice-President and Director of the Issuer. Other Health Care Decline to Disclose 06b true 0001557336-13-000001 2012-08-27 true true true 0 Indefinite 9540646 Indefinite false 5 0 0 0 false RxInnovation Inc. John Wissel John Wissel Secretary of the Issuer 2014-09-05